Società Immune Pharmaceuticals, Inc.
Azioni
FZRQ
US45254C2008
Prodotti farmaceutici
Attività
Numero di dipendenti: 7
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Chief Executive Officer | 37 | 12/04/21 | |
Devin J. Shaw
DFI | Director of Finance/CFO | 37 | 13/04/21 |
John Zhang
CTO | Chief Tech/Sci/R&D Officer | - | 11/12/17 |
Tony Fiorino
BRD | Director/Board Member | 56 | 15/08/17 |
Boris Shor
PRN | Corporate Officer/Principal | - | - |
John P. Clark
AUD | Comptroller/Controller/Auditor | 52 | 20/11/17 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
David Sidransky
BRD | Director/Board Member | 64 | - |
Tony Fiorino
BRD | Director/Board Member | 56 | 15/08/17 |
John A. Neczesny
BRD | Director/Board Member | 60 | 02/02/16 |
Daniel Kazado
BRD | Director/Board Member | 59 | 10/10/13 |
Jeff Paley
BRD | Director/Board Member | 55 | 23/02/16 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 0 | 3 713 | 0 | 0 | 100,00 % |
Azione B | 1 | 172 878 093 | 172 878 093 ( 100,00 %) | 0 |
Coordinate società
Immune Pharmaceuticals, Inc.
1 Bridge Plaza North Suite 270
07024, Englewood Cliffs
+201-464-2677
http://www.immunepharma.comSettore
Variaz. 1 gen. | Capi. | |
---|---|---|
+30,38% | 684 Mrd | |
+26,51% | 568 Mrd | |
-4,36% | 361 Mrd | |
+19,30% | 329 Mrd | |
+3,73% | 284 Mrd | |
+16,70% | 240 Mrd | |
+8,78% | 208 Mrd | |
-7,93% | 200 Mrd | |
+7,68% | 166 Mrd |